人角膜间充质基质细胞来源外泌体促进角膜上皮愈合
本研究从人尸体角膜分离角膜间充质基质细胞(cMSC)并提取外泌体,在体外划痕实验和小鼠2 mm上皮刮除模型中评估其对角膜上皮愈合的作用。结果显示cMSC外泌体可被角膜上皮细胞等摄取,体外16小时和体内72小时均显著加速愈合。
要点
- cMSC外泌体形态圆、直径主群40–100 nm,表达CD9、CD63、CD81。
- 体外划痕16小时,外泌体组剩余创面30.1%±14%,对照72.9%±8%(P<0.005)。
- 小鼠2 mm上皮刮除后72小时,外泌体组愈合77.5%±3%,对照41.6%±7%(P<0.05)。
核心结论
- 人cMSC来源外泌体可加速角膜上皮创面愈合,可能为眼表损伤提供治疗途径。
研究设计与样本
- 从人尸体角膜分离cMSC,收集72小时分泌组,差速超速离心分离外泌体。
- 体外用划痕实验、体内用小鼠2 mm角膜上皮刮除模型评估愈合效果。
主要发现
- cMSC外泌体形态圆,主群直径40–100 nm,表达CD9、CD63、CD81,不表达GM130、Calnexin、Cytochrome-C。
- 标记外泌体可被human cMSC、人角膜上皮细胞(HCEC)、人巨噬细胞体外摄取,也可被角膜上皮体内摄取。
- 体外划痕16小时,外泌体处理HCEC剩余创面30.1%±14%,对照72.9%±8%(P<0.005)。
- 小鼠2 mm上皮刮除后72小时,外泌体组角膜愈合77.5%±3%,对照41.6%±7%(P<0.05)。
临床怎么用
- 提示cMSC外泌体可能作为促进角膜上皮愈合的无细胞治疗候选,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Mesenchymal stromal cells (MSCs) have been used therapeutically to modulate inflammation and promote repair. Extracellular vesicles, including exosomes, have been identified as one of the important mediators. This study investigated the effect of human corneal MSC-derived exosomes on corneal epithelial wound healing. METHODS: Corneal MSCs (cMSCs) were isolated from human cadaver corneas. The secretome was collected after 72 hours and exosomes were isolated using differential ultracentrifugation. Morphology and size of exosomes were examined by electron microscopy and dynamic light scattering. Expression of CD9, CD63, and CD81 by cMSC exosomes was evaluated by western blotting. Cellular uptake of exosomes was studied using calcein-stained exosomes. The effect of exosome on wound healing was measured in vitro using a scratch assay and in vivo after 2-mm epithelial debridement wounds in mice. RESULTS: cMSC exosomes were morphologically round and main population ranged between 40 and 100 nm in diameter. They expressed CD9, CD63, and CD81, and did not express GM130, Calnexin, and Cytochrome-C. Stained cMSC exosomes were successfully taken up by human cMSCs, human corneal epithelial cells (HCECs), and human macrophages in vitro and by corneal epithelium in vivo. In scratch assay, after 16 hours, cMSC exosome treated HCECs had 30.1% ± 14% remaining wound area compared to 72.9% ± 8% in control (P < 0.005). In vivo, after 72 hours, cMSC exosome-treated corneas had 77.5% ± 3% corneal wound healing compared to 41.6% ± 7% in the control group (P < 0.05). CONCLUSIONS: Human cMSC exosomes can accelerate corneal epithelial wound healing, and thus, may provide a therapeutic approach for ocular surface injuries.
引用
- Samaeekia R, Rabiee B, Putra I, et al. Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing. Invest Ophthalmol Vis Sci. 2018. PMID: 30372747. doi:10.1167/iovs.18-24803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。